🇺🇸 FDA
Patent

US 8815885

Methods and compositions for modulating IRE1, SRC, and ABL activity

granted A61KA61K31/4155A61K31/497

Quick answer

US patent 8815885 (Methods and compositions for modulating IRE1, SRC, and ABL activity) held by The Regents of the University of California expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4155, A61K31/497, A61P, A61P21/00